Management of lung cancer-associated anaemia: The Spanish Lung Cancer Anaemia Survey (SLCAS)

Clinical and Translational Oncology

Volumn 13, Issue 5, 2011, Pages 328-334

  Gascón, Pere ^a,b   Almenárez, José ^c   Artal, Ángel ^d   Camps, Carlos ^e   Fírvida, José Luis ^f   Garrido, Pilar ^g   González Larriba, José Luis ^h   Montalar, Joaquín ⁱ  

^a HOSPITAL CLÍNIC   (Spain)

^b ONVIDA Group   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f Servicio Gallego de Salud   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Anaemia; Chemotherapy; Erythropoiesis stimulating agents; Lung cancer; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; QUALITY OF LIFE; SPAIN;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; FEMALE; HEMATINICS; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SPAIN;

EID: 79960673078     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0662-5     Document Type: Article

References (24)

1. Birgegard G, Aapro MS, Bokemeyer C et al (2005) Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 68[Suppl 1]:3-11 (Pubitemid 40663255)
2. Ludwig H, Van Belle S, Barrett-Lee P et al (2004) The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defi ning the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40:2293-2306 (Pubitemid 39348881)
3. Crawford J, Kosmidis PA, Hirsch FR, Langer CJ (2006) Targeting anemia in patients with lung cancer. J Thorac Oncol 1:716-725 (Pubitemid 47163963)
4. Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91:2214-2221 (Pubitemid 32552805)
5. Van Belle SJ, Cocquyt V (2003) Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 47:1-11 (Pubitemid 36802321)
6. Clarke H, Pallister CJ (2005) The impact of anaemia on outcome in cancer. Clin Lab Haematol 27:1-13 (Pubitemid 40293371)
7. Barrett-Lee PJ, Ludwig H, Birgegard G et al (2006) Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey. Oncology 70:34-48
8. Groopman JE, Itri LM (1999) Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91:1616-1634 (Pubitemid 29479929)
9. Vincent M, Dranitsaris G, Verma S et al (2007) The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy. Support Care Cancer 15:265-272 (Pubitemid 46295217)
10. Bokemeyer C, Aapro MS, Courdi A et al (2007) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 43:258-270 (Pubitemid 46127840)
11. Rizzo JD, Brouwers M, Hurley P et al (2010) American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116:4045-4059
12. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655 (Pubitemid 13149996)
13. Zubrod CG, Schneiderman M, Frei E III (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11:7-33
14. Kosmidis P, Krzakowski M (2005) Anemia profi les in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)? Lung Cancer 50:401-412
15. Biesma B, van de Werf PR, Melissant CF, Brok RG (2007) Anaemia management with epoetin alfa in lung cancer patients in The Netherlands. Lung Cancer 58:104-111 (Pubitemid 47381551)
16. Dempke W (2007) Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer. Anticancer Res 27:1745-1757 (Pubitemid 46954672)
17. de Castro J, Belda-Iniesta C, Isla D et al (2008) Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study. Lung Cancer 59:211-218 (Pubitemid 351173408)
18. Khuri FR (2007) Weighing the hazards of erythropoiesis stimulation in patients with cancer. N Engl J Med 356:2445-2448 (Pubitemid 46919767)
19. FDA (2007) FDA strengthens boxed warnings, approves other safety labeling changes for erythropoiesis-stimulating agents (ESAs). http://www.fda.gov/bbs/ topics/news/2007/new01740.html. November 8
20. Aapro M, Van Erps J, MacDonald K et al (2009) Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: initial evidence from the RESPOND study. Eur J Cancer 45:8-11
21. Gascon P (2008) Safety update on erythropoiesisstimulating agents: trials within and outside the accepted indications. Oncologist 13:4-10
22. Bennett CL, Silver SM, Djulbegovic B et al (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299:914-924 (Pubitemid 351397066)
23. Bohlius J, Schmidlin K, Brillant C et al (2009) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373:1532-1542
24. Bohlius J, Schmidlin K, Brillant C et al (2009) Erythropoietin or darbepoetin for patients with cancer: meta-analysis based on individual patient data. Cochrane Database Syst Rev (3):CD007303